These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25065495)

  • 1. Novelty processing and memory formation in Parkinson's disease.
    Schomaker J; Berendse HW; Foncke EM; van der Werf YD; van den Heuvel OA; Theeuwes J; Meeter M
    Neuropsychologia; 2014 Sep; 62():124-36. PubMed ID: 25065495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of novelty repetition in Parkinson's disease: A study of P3 event-related brain potentials.
    Bertram M; Warren CV; Lange F; Seer C; Steinke A; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B
    Clin Neurophysiol; 2020 Dec; 131(12):2841-2850. PubMed ID: 33137574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
    Maier F; Merkl J; Ellereit AL; Lewis CJ; Eggers C; Pedrosa DJ; Kalbe E; Kuhn J; Meyer TD; Zurowski M; Timmermann L
    Parkinsonism Relat Disord; 2014 Apr; 20(4):421-7. PubMed ID: 24467817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological analysis of the role of novelty in the von Restorff effect.
    Rangel-Gomez M; Meeter M
    Brain Behav; 2013 Mar; 3(2):159-70. PubMed ID: 23531713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
    Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
    Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The source of the memory impairment in Parkinson's disease: acquisition versus retrieval.
    Chiaravalloti ND; Ibarretxe-Bilbao N; DeLuca J; Rusu O; Pena J; García-Gorostiaga I; Ojeda N
    Mov Disord; 2014 May; 29(6):765-71. PubMed ID: 24615718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.
    Brønnick K; Alves G; Aarsland D; Tysnes OB; Larsen JP
    Neuropsychology; 2011 Jan; 25(1):114-24. PubMed ID: 20954781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
    Maril S; Hassin-Baer S; Cohen OS; Tomer R
    Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The speed of lexical activation is altered in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.
    Leplow B; Sepke M; Schönfeld R; Pohl J; Oelsner H; Latzko L; Ebersbach G
    J Neural Transm (Vienna); 2017 Feb; 124(2):217-225. PubMed ID: 27848033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Event-related desynchronization/synchronization during an auditory-verbal working memory task in mild Parkinson's disease.
    Ellfolk U; Karrasch M; Laine M; Pesonen M; Krause CM
    Clin Neurophysiol; 2006 Aug; 117(8):1737-45. PubMed ID: 16807091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory deficits in Parkinson's disease.
    Whittington CJ; Podd J; Stewart-Williams S
    J Clin Exp Neuropsychol; 2006 Jul; 28(5):738-54. PubMed ID: 16723322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
    Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
    Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.